A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease

Troeung, Lakkhina; Egan, Sarah J.; Gasson, Natalie

doi:10.1186/1471-244x-14-19

Cited by 69 publications

(74 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the combination of a nurse and a social worker can provide the most appropriate answers for medical and social issues, whereas psychologists and speech and language therapists can be most effective in dealing with issues concerning communication. Thus, group therapy has been gaining increasing attention as an efficient and effective means of long-term therapy [19,20].…”

Section: Community Rehabilitation Facilitymentioning

confidence: 99%

Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families

Giladi

Manor

Hilel

et al. 2014

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

Parkinson's disease (PD) is a chronic progressive neurodegenerative and multidimensional disease that involves a range of disabling motor and nonmotor symptoms. These symptoms can have a major impact on the quality of life of PD patients. The focus of this article is to stress the importance of the interdisciplinary team intervention approach in the treatment of patients with PD. The team approach uses experts in PD from different health care professions, including a neurologist, a nurse, a speech and language therapist, a physiotherapist, a social worker, a psychiatrist, an occupational therapist, a sexologist, and a dietician. The major aim of the team and of teamwork is to provide professional care in all motor and nonmotor aspects of PD throughout the course of the disease. There are different models of multidisciplinary teams: inpatient facility, community rehabilitation facility, and synchronized multiprofessional treatment in the community. The Tel Aviv Sourasky Medical Center model of interdisciplinary care was designed to create a coordinated multidisciplinary team in the Movement Disorders Unit. The role of each team member and their professional objective are described. Their collaboration is by design a promotion of a team goal for maintaining and enhancing the quality of life of PD patients and their families.

show abstract

Section: Community Rehabilitation Facilitymentioning

confidence: 99%

Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families

Giladi

Manor

Hilel

et al. 2014

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

show abstract

“…The CBT courses consisted of 6–12 weekly sessions and modified the typical CBT regime to include a stronger emphasis on relaxation modules, behavioural activation, problem-solving and psychoeducation 25 27 29. In addition, several studies included modules specific to PD: activity scheduling around on-off effects, motor symptoms as triggers of anxiety, fear of falling and preparation for disease progression 27 29. In some instances, there were further modifications to the CBT protocol to accommodate the executive and somatic features of PD: less written material provided to patients, unlimited breaks during session to allow patients to attend to their needs 29.…”

Section: Resultsmentioning

confidence: 99%

Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

Koychev

Okai

2017

Evid Based Mental Health

View full text Add to dashboard Cite

Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact on quality of life and carer burden. Pharmacological treatment is the main approach in dealing with these symptoms, but it is limited by variable efficacy and risk of drug interactions. Non-pharmacological approaches using the cognitive-behavioural therapy (CBT) model are viable alternatives and in this review paper we summarise the evidence of CBT for three of the most common psychiatric manifestations of PD: depression and anxiety, impulse-control disorders and insomnia. Most studies modified the usual CBT format to include modules accounting for problems specific to PD: activity scheduling around motoric function, motor symptoms as triggers of anxiety, fear of falling and preparation for disease progression as well as accommodation of materials for suspected executive dysfunction. We found a growing evidence base that CBT (modified to account for PD-specific problems) is effective in the treatment of PD psychiatric symptoms. Where controlled study design was used, moderate effect sizes are reported for the efficacy of CBT for depression, including with distance administration of CBT. The effects were sustained during follow-up which was between 1 and 6 months. In addition, there are some initial data on the effects of CBT on impulse-control disorders and insomnia. The studies were limited by their small and potentially unrepresentative samples and the quality of sample reporting (eg, concomitant antidepressant and dopaminergic therapy use). Additional welldesigned and adequately powered studies are required to determine the utility of CBT in PD. INTRODUCTIONParkinson's disease (PD) is classically defined by a triad of motor symptoms (tremor, rigidity and bradykinesia). It is, however, increasingly conceptualised as a neuropsychiatric disorder 1 in view of the high prevalence of psychiatric features, including depression, impulse control disorders (ICD) and sleep difficulties.2 These non-motor complications are better predictors of disability, distress and rates to institutionalisation than the motor symptoms.3 Of the non-motor complications, mixed depression and anxiety is the most common psychiatric comorbidity, affecting ∼50% of PD patients, significantly more common that rates in the general population.4 Depression and anxiety are the strongest predictors of poorer quality of life, 5 even in the advanced stages of the illness where the motor features have progressed fully.6 ICD are characterised by repetitive, reward-based behaviours, linked to the dopaminergic medication used to treat the motor symptoms. They affect ∼14% of all PD patients 7 and are associated with psychiatric comorbidity and high carer burden.8 Sleep disturbance is another neuropsychiatric symptom that affects up to 60% of all PD patients.9 It is associated with somnolence 10 and impairment in attention and executive function.11 On the basis of their impact on quality of life and outcome, the recognition and treatment of neuropsych...

show abstract

“…An open-label trial of CBT was reported as helpful [86] but a DBPCT of venlafaxine or paroxetine for treating depression, and not powered for anxiety, did not find a beneficial effect for the anxiety, although the drugs did improve depression. The ADAGIO trial, which was intended to demonstrate the effect of rasagaline, an MAOb inhibitor on motor progression in early, untreated PD, and not powered for non-motor problems, nevertheless found some benefit for rasagaline and antidepressant treatment depression but not for anxiety [87].…”

Section: Anxietymentioning

confidence: 95%

Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease

Akbar

Friedman

2015

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

The non-motor symptoms of Parkinson's disease (PD) have been attracting increasing attention due to their ubiquitous nature and their often devastating effects on the quality of life. Behavioral problems in PD include dementia, depression, apathy, fatigue, anxiety, psychosis, akathisia, personality change, sleep disorders and impulse control disorders. Some of these are intrinsic to the neuropathology while others occur as an interplay between pathology, psychology and pharmacology. While few data exist for guiding therapy, enough is known to guide therapy in a rational manner.

show abstract

A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease

Cited by 69 publications

References 42 publications

Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families

Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families

Cognitive–behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review

Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease

Contact Info

Product

Resources

About